Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account
Avatar photo

Maryellen Guinan

Policy Manager

Maryellen Guinan is a principal policy analyst at America's Essential Hospitals.

CDC reports lower in-hospital mortality rates from the omicron variant, providers have until Sept. 30 to report period 3 Provider Relief Fund spending.

view more »

America's Essential Hospitals urges CMS to swiftly restore full Medicare Part B drug payment rates for hospitals in the 340B Drug Pricing Program and define a select group of hospitals with a safety net mission.

view more »

The Biden administration's fall plan to manage the COVID-19 pandemic includes securing millions of updated vaccines and additional at-home, rapid tests; ensuring vaccine access for higher-risk Americans; and fostering community conversations about updated vaccines.

view more »

The agency requests information on health care access and equity, provider experiences, and the effect of policies introduced in response to COVID-19.

view more »

The association urged CMS to adequately reimburse off-campus, provider-based departments; refine physician quality reporting; and codify a definition of essential hospitals.

view more »

CDC recommends updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

view more »

CMS on Aug. 29 finalized its decision to delay indefinitely implementation of the Radiation Oncology Model, which was scheduled to start Jan. 1, 2023.

view more »

No-cost, at-home COVID-19 tests no longer will be offered through the United States Postal Service, CDC releases a fall vaccination plan, and FDA warns prescribers about Paxlovid drug interactions.

view more »

Pfizer applies for emergency use authorization for its omicron-specific booster vaccine, the National Healthcare Safety Network will take over hospital data reporting, and CMS tells hospitals to brace for the public health emergency's end.

view more »

CDC updated its COVID-19 safety guidelines, FDA warned of false negative test risks, and bebtelovimab will transition to the commercial marketplace.

view more »

HHS releases two new reports on long COVID-19 research and support, while the Administration for Strategic Preparedness & Response shares guidance on Paxlovid efficacy and eligibility.

view more »

The declaration enables HHS to modify Medicare and Medicaid program requirements and could lead to more emergency funding for virus prevention and vaccines.

view more »

Health care providers have until Aug. 30 to download their preview reports before CMS shares quality data publicly in October.

view more »

As monkeypox continues to spread, New York health leaders declare the virus an imminent threat, while California leaders request additional vaccine supply.

view more »

This is the second star ratings update since the agency updated its methodology in 2020 to include the use of peer grouping.

view more »

HHS agreed to purchase 66 million Moderna bivalent COVID-19 vaccine doses, while the CDC reported fewer vaccine reactions for those older than 50 who receive a second mRNA booster shot.

view more »

As the World Health Organization declares monkeypox a global health emergency, CDC updates clinical guidance, and HHS plans to allocate additional vaccine doses.

view more »

CDC recommends the Novavax COVID-19 vaccine for adults and reports that additional mRNA COVID-19 vaccine booster doses increase protection against moderate and severe COVID-19.

view more »

Antimicrobial-resistant hospital-onset infections and deaths both increased from 2019 to 2020, according to a new CDC analysis.

view more »

CMS seeks feedback at a July 21 listening session on the 5 percent lump sum Alternative Payment Model Incentive Payment, set to expire at the end of 2022. 

view more »

FDA approves the Novavax COVID-19 vaccine for those 18 and older as the Biden-Harris administration releases an action plan to take on the BA.5 subvariant.

view more »

FDA approves the Pfizer COVID-19 vaccine for use in individuals ages 12 to 15 and authorizes state-licensed pharmacists to prescribe Paxlovid.

view more »

The document outlines five priority goals to improve maternal health and outcomes and, for each, actions the federal government will take.

view more »

The strategy aims to deploy vaccines rapidly in the most affected communities, facilitate testing, and engage stakeholders to mitigate spread.

view more »

FDA advises vaccine manufacturers to incorporate an omicron variant component into booster doses; Pfizer requests FDA approval of antiviral pill Paxlovid.

view more »

CDC recommends the Moderna vaccine for kids ages 6 to 17; an FDA committee will consider modifying COVID-19 vaccine composition to reflect virus mutations.

view more »

CDC recommends that children ages 6 months to 5 years receive a COVID-19 vaccine; Pfizer study data shows Paxlovid failed to alleviate COVID-19 symptoms.

view more »

The Florida Department of Health does not recommend COVID-19 vaccines for "healthy children" and will not facilitate statewide vaccine distribution; health care providers still may order vaccines directly from the federal government.

view more »

The order instructs the HHS Secretary to use the agency's authorities to protect LGBTQI+ individuals' access to medically necessary care.

view more »

America's Essential Hospitals commented on several policy proposals of interest to essential hospitals and responded to requests for information on maternal health, equity, and climate change.

view more »

CDC no longer requires a negative COVID-19 test or proof of COVID-19 recovery from travelers to the United States; an FDA advisory committee recommends the Novavax vaccine.

view more »
Load More
Previous Next
Close
Test Caption
Test Description goes like this